Who is sponsoring NCT02610608?

NCT02610608 is sponsored by University Hospital, Brest.

What drugs are being tested in NCT02610608?

Interventions in NCT02610608: ovarian stimulation.

What condition does NCT02610608 study?

NCT02610608 studies Ovarian Hyperstimulation Syndrome, Cardiovascular Diseases, Embolism and Thrombosis.

Is NCT02610608 still recruiting?

NCT02610608 is currently terminated. Last updated 10 July 2020.

Last reviewed 2020-07-10 · How we verify

NCT02610608: AMPERT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medical Assistance for the Procreation and Risk of Thrombosis.

Terminated Last updated 10 July 2020

What this trial tests

trial testing ovarian stimulation in Ovarian Hyperstimulation Syndrome in 129 participants. Terminated before completion.

Timeline

2 February 2016

Primary endpoint
20 November 2016

20 November 2016

Quick facts

Lead sponsor	University Hospital, Brest
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	129
Start date	2 February 2016
Primary completion	20 November 2016
Estimated completion	20 November 2016
Sites	9 locations across France

Drugs / interventions tested

ovarian stimulation — full drug profile →

Conditions studied

Ovarian Hyperstimulation Syndrome — all drugs for Ovarian Hyperstimulation Syndrome →
Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Embolism and Thrombosis — all drugs for Embolism and Thrombosis →

Sponsor

University Hospital, Brest

Who can join

18 and older, female only, with Ovarian Hyperstimulation Syndrome or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims at evaluating clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation. Secondary outcomes are : 1) to describe the incidence and risk factors of arterial and venous thrombosis in women undergoing assisted reproductive technology and 2)to identify the incidence and risk factors for ovarian hyperstimulation syndrome in these women

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02610608 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 10 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02610608.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing